AccessMyLibrary provides FREE access to over 30 million articles from top publications available through your library.

FDA approves generic versions of popular osteoporosis drug.(IN THE NEWS)

Health News

| April 01, 2008 | COPYRIGHT 2008 Belvoir Media Group, LLC. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan.  All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)Copyright

[ILLUSTRATION OMITTED]

The U.S. Food and Drug Administration (FDA) approved the first generic versions of the popular osteoporosis drug Fosamax (alendronate) on February 6, 2008. Fosamax, made by Merck & Co., is among the top 100 most frequently dispensed drugs in the united states. Currently Fosamax costs $80 to $85 per month. Although generic drugs are chemically identical to their branded counterparts, they are sold at substantial discounts. Teva Pharmaceuticals USA will manufacture the generic ...

Related articles from newspapers, magazines, journals, and more
Amgen near breakthrough on osteoporosis drug.
Newspaper article from: Denver Post (Denver, CO) Johnson, Kimberly S. August 10, 2005 700+ words
...testing of what could be a breakthrough osteoporosis drug that would be produced in Boulder...in San Francisco. By 2006, the osteoporosis drug market will reach $11.5 billion...prescribed Fosamax, the leading osteoporosis drug. (She is not a part of Amgen...
OSTEOPOROSIS DRUG WORKS IN MEN, STUDY REVEALS TREATMENT ONLY OK'D FOR...
Newspaper article from: The Cincinnati Post (Cincinnati, OH) September 1, 2000 700+ words
...of Medicine, is the first large study of men given an osteoporosis drug. ''We perceive it as a women's disease and have totally...for postmenopausal osteoporosis and is the top-selling osteoporosis drug. Fosamax and another drug, Actonel, are approved for...
New Osteoporosis Drug Appears to Build Bone.
Newspaper article from: Knight Ridder/Tribune Business News May 10, 2001 700+ words
...experimental drug Forteo appears to do something better than any osteoporosis drug on the market: actually build bone, even in frail, elderly...human protein that regulates calcium, expects to put the osteoporosis drug on the market this year. The U.S. Food and Drug Administration...
NovaDx discovers osteoporosis drug opportunities; drug & diagnostic research...
Press release article from: Business Wire April 22, 1997 700+ words
...is pleased to announce the discovery of new targets for osteoporosis drug development. These proteins were identified by the Company...pharmaceutical partner to assist in the development of these new osteoporosis drug opportunities. -0- NOTE: The Vancouver Stock Exchange...
Dual-Action Osteoporosis Drug Candidate Targeting Critical Disease Gene...
Press release article from: Business Wire October 16, 2000 700+ words
...initial results of in vivo studies on its small-molecule osteoporosis drug, demonstrating not only inhibition of bone breakdown but...of new bone formation. Development of a dual-action osteoporosis drug that affects both stages of the normal process of bone...
New cancer weapon: Osteoporosis drug cuts breast cancer risk with fewer side...
Newspaper article from: Newsday (Melville, NY) April 18, 2006 700+ words
...chances of developing the disease are high. Raloxifene, an osteoporosis drug sold as Evista, reduced the risk of invasive breast cancer...product of Eli Lily Inc., raloxifene is approved only as an osteoporosis drug. Three of the study's participants, who accompanied...
An easier option for osteoporosis? Drug promising, 2 studies suggest; Lower...
Newspaper article from: The Seattle Times (Seattle, WA) August 12, 2009 700+ words
...Associated Press and Los Angeles Times A first-of-its-kind osteoporosis drug lowers the risk of bone fractures better than some existing...to produce, and it figures to be the highest-priced osteoporosis drug in a crowded marketplace. The most well-known of these...
Osteologix Secures Positive JPO Patent Decision for Key Osteoporosis Drug
Newspaper article from: Wireless News August 24, 2009 700+ words
...Osteologix Secures Positive JPO Patent Decision for Key Osteoporosis Drug Type: News Osteologix, Inc. announced that the Japan...using NB S101 (strontium malonate), the Company's lead osteoporosis drug candidate. The Company expects the patent will issue by...
For more facts and information, see all results
©2009 Gale, a part of Cengage Learning. All rights reserved.
About us | FAQs | Contact us | Privacy policy | Terms and conditions
Other Gale sites: Encyclopedia.com | HighBeam Research | Acquire Content | Books & Authors | Goliath | MovieRetriever | Smart QandA